Anti-Hsp27 antibody
4
(1 Review)
|
(22 Publications)
Rabbit Polyclonal Hsp27 antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human, African green monkey, Mouse, Rat, Vervet monkey samples. Cited in 22 publications. Immunogen corresponding to Synthetic Peptide within Human HSPB1 aa 1-50.
View Alternative Names
HSP27, HSP28, HSPB1, Heat shock protein beta-1, HspB1, 28 kDa heat shock protein, Estrogen-regulated 24 kDa protein, Heat shock 27 kDa protein, Heat shock protein family B member 1, Stress-responsive protein 27, HSP 27, SRP27
- ICC/IF
Collaborator
Immunocytochemistry/ Immunofluorescence - Anti-Hsp27 antibody (AB5579)
HeLa (human epithelial cell line from cervix adenocarcinoma) cells were fixed with 4% formaldehyde in PEM buffer. The coverslip was incubated in blocking buffer of 5% powdered milk in TBS-T plus 0.02% sodium azide for 1 hour at room temperature. Blocking buffer was removed and primary antibody was added at a dilution of 1/250 and incubated overnight at 4 degrees celsius. The coverslips were then washed 4-5 times with blocking buffer for 5 minutes. Secondary antibody, goat anti-rabbit Alexa 594 (ab150080), was added at a dilution of 1/1000 and incubated at room temperature for one hour. From this point on coverslips were covered with foil to protect them from light. They were washed 5 times with TBS-T and then one time with PEM, for 5 minutes each wash. The coverslips were fixed 10-30 minutes in 4% formaldehyde in PEM buffer, then washed 3 times with PEM buffer for 5 minutes. 0.1M ammonium chloride in PEM buffer was added for 10 minutes to quench auto-florescence, and then slips were washed 2 times for 5 minutes in PEM followed by 3 washes for 5 minute
This image is courtesy of Michael Manicini, Ph.D.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Hsp27 antibody (AB5579)
Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Hsp27 (green) with ab5579 at 1/200 dilution, followed by DyLight 488-conjugated secondary antibody. F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue). Cells were fixed with formaldehyde and incubated with the primary antibody overnight at 4°C. 60X magnification. Right - negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hsp27 antibody (AB5579)
Immunohistochemical analysis of both normal and cancer biopsies of deparaffinized human skeletal muscle tissue labeling Hsp27 with ab5579 at 1/20 dilution or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP, followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.
To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH 6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Hsp27 antibody (AB5579)
Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma cell line) cells labeling Hsp27 (green) with ab5579 at 1/200 dilution, followed by DyLight 488-conjugated secondary antibody. F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue). Cells were fixed with formaldehyde and incubated with the primary antibody overnight at 4°C. 60X magnification. Right - negative control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hsp27 antibody (AB5579)
Immunohistochemical analysis of both normal and cancer biopsies of deparaffinized human breast carcinoma tissue labeling Hsp27 with ab5579 at 1/100 dilution or without primary antibody (negative control) overnight at 4°C in a humidified chamber. Tissues were washed extensively with PBST and endogenous peroxidase activity was quenched with a peroxidase suppressor. Detection was performed using a biotin-conjugated secondary antibody and SA-HRP, followed by colorimetric detection using DAB. Tissues were counterstained with hematoxylin and prepped for mounting.
To expose target proteins, heat induced antigen retrieval was performed using 10mM sodium citrate (pH6.0) buffer, microwaved for 8-15 minutes. Following antigen retrieval tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Hsp27 antibody (AB5579)
Immunofluorescence analysis of C6 (Rat glial tumor cell line) cells labeling Hsp27 (green) with ab5579 at 1/100 dilution, followed by DyLight 488-conjugated secondary antibody. F-Actin staining with Phalloidin (red) and nuclei with DAPI (blue). Cells were fixed with formaldehyde and incubated with the primary antibody overnight at 4°C. 60X magnification. Right - negative control.
- WB
Supplier Data
Western blot - Anti-Hsp27 antibody (AB5579)
All lanes:
Western blot - Anti-Hsp27 antibody (ab5579) at 1/2000 dilution
Lane 1:
MCF7 (human breast adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 2:
MDA-MB-231 (human breast adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 3:
PC3 (human prostate adenocarcinoma cell line) whole cell lysate at 30 µg
Lane 4:
DU 145 (human prostate carcinoma cell line) whole cell lysate at 30 µg
Lane 5:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 30 µg
Lane 6:
LNCaP (human prostate cancer cell line) whole cell lysate at 30 µg
Lane 7:
HT1080 (human fibrosarcoma cell line) whole cell lysate at 30 µg
Secondary
All lanes:
Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP at 1/4000 dilution
Predicted band size: 23 kDa
false
- WB
Supplier Data
Western blot - Anti-Hsp27 antibody (AB5579)
All lanes:
Western blot - Anti-Hsp27 antibody (ab5579) at 1/1000 dilution
Lane 1:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 50 µg
Lane 3:
K562 (human chronic myelogenous leukemia lymphoblast cell line ) whole cell lysate at 50 µg
Lane 4:
A431 (human epidermoid carcinoma cell line) whole cell lysate at 50 µg
Lane 5:
HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate at 50 µg
Lane 6:
COS-7 (african green monkey kidney fibroblast-like cell line) whole cell lysate at 50 µg
Lane 7:
NIH/3T3 (mouse embryonic fibroblast cell line) whole cell lysate at 50 µg
Secondary
All lanes:
Goat anti-rabbit IgG-HRP secondary antibody at 1/20000 dilution
Predicted band size: 23 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Hsp27 plays a critical role in cellular stress response by regulating actin cytoskeleton dynamics and inhibiting apoptosis. It forms part of a complex that includes other proteins such as alphaB-crystallin. This complex facilitates the reorganization of proteins under stress conditions enhancing cell survival during oxidative stress or thermal shock. Hsp27 also modulates inflammatory responses and has been shown to affect cell migration.
Pathways
Hsp27 integrates into the apoptosis and inflammation pathways. It interacts with apoptotic machinery such as caspase proteins to protect cells by hindering apoptosome formation. Additionally Hsp27 can engage with pathways involving the nuclear factor-kappa B (NF-kB) impacting inflammatory signaling. CPTC (carboxyl-pyrene-trioctylamine) can modulate these pathways by altering Hsp27 function and interactions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Journal of xenobiotics 15: PubMed40981348
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and experimental pharmacology & physiology 51:e13857 PubMed38566371
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 12:4605-4615 PubMed36200687
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:719187 PubMed34765600
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological macromolecules 182:1371-1383 PubMed34004199
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 19:3133-3142 PubMed32256801
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cellular signalling 63:109384 PubMed31394193
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 20:2410-2418 PubMed31322176
2019
Applications
Unspecified application
Species
Unspecified reactive species
Investigational new drugs 38:350-359 PubMed31124054
2019
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 145: PubMed29180567
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com